Evaluation of the Collaborate to Innovate: London Diagnostics Programme Report 2024
Sector insightsEvaluating the impact of London’s collaborative diagnostics cluster and how partnership models are accelerating innovation.
Overview
This independent evaluation, conducted by KADA Research, reviews the impact of the Collaborate to Innovate: London Diagnostics Programme. Commissioned by MedCity, the study examines how the programme supported diagnostic SMEs, academic groups and NHS partners to collaborate and accelerate innovation. The findings show that targeted funding and facilitation improved translation, adoption and commercialisation of new diagnostics across London. The report identifies key success factors, including strong coordination, consistent evaluation and open communication between partners and provides recommendations for future regional innovation clusters.
Key takeaways
- Collaboration created measurable impactIndependent evaluation found that partnership models between industry, academia and healthcare improved innovation delivery and strengthened London’s diagnostics infrastructure.
- Programme design supported scaleupTargeted support helped diagnostics companies validate technologies and progress towards commercial readiness, building capacity for future collaboration.
- Framework for future programmesThe evaluation recommends maintaining coordinated leadership, shared data frameworks and long-term investment to embed innovation across the diagnostics sector.
